These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32023215)

  • 21. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study.
    Byrne J; Wyraz A; Velasco-Torrijos T; Reinhardt R
    Pharm Dev Technol; 2017 Jun; 22(4):537-544. PubMed ID: 26895450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation.
    Hong J; Lee E; Carter JC; Masse JA; Oksanen DA
    Pharm Dev Technol; 2004; 9(2):171-9. PubMed ID: 15202576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative degradation in pharmaceuticals: Mechanism and stabilization of a spray-dried amorphous drug - A case study.
    Kotha RR; Zhang K; Yehl P; Kumar A
    J Pharm Biomed Anal; 2022 Oct; 220():114962. PubMed ID: 35963017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylethyl resorcinol smartLipids for skin brightening - Increased loading & chemical stability.
    Köpke D; Müller RH; Pyo SM
    Eur J Pharm Sci; 2019 Sep; 137():104992. PubMed ID: 31302211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions.
    Damian F; Fabian J; Friend DR; Kiser PF
    Int J Pharm; 2010 Aug; 396(1-2):1-10. PubMed ID: 20510342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basics of Sterile Compounding: Vehicles Used in Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2019; 23(3):221-228. PubMed ID: 31085791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved.
    Allen LV
    Int J Pharm Compd; 2020; 24(1):44-50. PubMed ID: 32023216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanoradical-induced degradation in a pharmaceutical blend during high-shear processing.
    Polizzi MA; Singhal D; Colvin J
    Pharm Dev Technol; 2008; 13(6):457-62. PubMed ID: 18720240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of physical and chemical stability of ointment with herbals.
    Zdoryk OA; Khokhlova KO; Georgiyants VA; Vyshnevska LI
    Int J Pharm Compd; 2014; 18(3):248-52. PubMed ID: 25306773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique.
    Kawashima Y; Lin SY; Ueda M; Takenaka H; Ando Y
    J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations.
    Allen LV
    Int J Pharm Compd; 2019; 23(2):135-143. PubMed ID: 31085779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of refrigerated miglustat after preparation in InOrpha(®) flavored suspending excipient for compounding of oral solutions and suspensions.
    Riahi S; Ambühl M; Stichler J; Bandilla D
    Drug Des Devel Ther; 2015; 9():561-6. PubMed ID: 25632223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zinc oxide as a new antimicrobial preservative of topical products: interactions with common formulation ingredients.
    Pasquet J; Chevalier Y; Couval E; Bouvier D; Bolzinger MA
    Int J Pharm; 2015 Feb; 479(1):88-95. PubMed ID: 25527211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ensuring Product Stability - Choosing the Right Excipients.
    Veronica N; Heng PWS; Liew CV
    J Pharm Sci; 2022 Aug; 111(8):2158-2171. PubMed ID: 35526577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.